CTRI/2022/07/044079尚未招募未知
A Comparative Study Of Efficacy And Safety Of Bimatoprost And Timolol In Patients With Primary Open Angle Glaucoma.
Dr Sreyanwita Mukherjee0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age: 18 to 60 years of age of either sex.
- •Patients with newly diagnosed, drug naive, primary open angle glaucoma patients of either sex attending the Department of Ophthalmology OPD at College of Medicine & Sagore Dutta Hospital, Kamarhati, Kolkata.
- •Patient who will give the written informed consent form voluntarily and are available during the entire study duration.
排除标准
- •Pregnant or lactating women.
- •Patients who are suffering from other congenital glaucoma secondary to other ophthalmic conditions.
- •Patient who has undergone any kind of medical and surgical treatment in the past.
- •Patient who has undergone corrective refractive surgery.
- •Patients with uncontrolled Hypertension, Diabetes mellitus.
- •Patients receiving chemotherapy for Malignancy.
- •Patients having infection in one or both eyes within the last three months.
- •Patients having ocular injury within last three months.
- •Patients suffering from major systemic illness or features of severe systemic infection are excluded from the study.
研究者
相似试验
尚未招募
不适用
Comparison of bilastine 20mg versuslevocetrizine 5mg in chronic urticaria.CTRI/2021/08/035839IMS and SUM Hospital Bhubaneswar
已完成
4 期
BIAsp-3858Diabetes Mellitus Type II.Non-insulin-dependent diabetes mellitus type IIIRCT201104266297N1ovo Nordisk A/S300
尚未招募
1 期
Evaluation of the effectiveness and safety of bianshi moxibustion infrared dry eye therapeutic instrument in the treatment of meibomian gland dysfunctiomeibomian gland dysfunctionITMCTR1900002769Peking University Third Hospital
尚未招募
2 期
Effect of Nimba patra pindi and shigru patra pindi in the management of kaphaj abhishyanda w.s.r. to acute mucopurrulent conjunctivitisCTRI/2024/02/062841DR GAURAV PANYA
招募中
2 期
Evaluation of safety and the effectiveness of Bioba (Prime) anti-hair loss line (serum and shampoo)IRCT20190210042676N16Akhavi laboratory19
